Vivimed Labs Limited (VIVIMEDLAB) — Announcement
Vivimed Labs Limited announced the commencement of a Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, ordered by the NCLT Bengaluru Bench on 15 April 2026 (received 17 April 2026). Creditors must submit claims by 1 May 2026, with financial creditors filing electronically. The interim resolution professional is T. Narayana Swamy at VK Commerce, Bengaluru. The process is expected to conclude by 11 October 2026. This filing signals severe financial distress and potential restructuring or liquidation, directly impacting shareholder value.
About Vivimed Labs Limited (VIVIMEDLAB)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when VIVIMEDLAB files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track VIVIMEDLAB — Free💡 Ask AI about this filing
📊 More VIVIMEDLAB filings
- 🔴 Financial Results — 22 July 2026 Vivimed Labs Limited announced the publication of audited financial results for FY2026 in major news...
- share transfer — 22 July 2026 Vivimed Labs reported that its registrar, Aarthi Consultants, processed zero transfer requests for p...
- share transfer — 10 July 2026 Vivimed Labs Limited received a SEBI Regulation 74(5) compliance certificate from its RTA, Aarthi Co...
- Financial Results — 30 June 2026 Vivimed Labs Limited announced that its trading window will close on 01.07.2026 and remain closed un...
- Financial Results — 25 June 2026 Vivimed Labs Limited clarified that its financial results for the year ended March 31, 2025 were sub...
🔥 Also filed on 23 April 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when VIVIMEDLAB files new disclosures
Track VIVIMEDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track VIVIMEDLAB — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research